Investigating factors associated with medicinal cannabis authorization dosage among military Veterans in Canada

被引:0
作者
Mejia, Angela Czarina [1 ,3 ]
Koehoorn, Mieke [1 ]
Hall, Amy [2 ]
Davies, Hugh [1 ]
VanTil, Linda [2 ]
机构
[1] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada
[2] Vet Affairs Canada, Res Directorate, Charlottetown, PE, Canada
[3] Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, 2206 East Mall, Vancouver, BC V6T 1Z3, Canada
来源
JOURNAL OF MILITARY VETERAN AND FAMILY HEALTH | 2023年 / 9卷 / 05期
关键词
authorization dosage; CAF; Canada; Canadian Armed Forces; cannabis; medicinal cannabis; military; VAC; Veterans; Veterans Affairs Canada; POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH; AVAILABILITY; PREVALENCE; MANAGEMENT; DEPLOYMENT; GENDER; TRENDS; RISK; CARE;
D O I
10.3138/jmvfh-2022-0080
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: Since 2008, Veterans Affairs Canada (VAC) has provided Canadian Armed Forces Regular Force Veterans with reimbursement of Cannabis for Medical Purposes (CMP) authorizations. The authorized dosage and authorization criteria have changed with time. This study investigated factors associated with CMP authorizations and dosage among CMP-authorized Veterans. Methods: CMP authorizations among 9,104 Veterans residing in Canada on Dec. 31, 2020, were linked with VAC reimbursement, VAC client, and military personnel records. Multivariable logistic regression models were used to examine relationships between CMP dosage and socio-demographic, health, and military characteristics. Results: Among Veterans with CMP authorizations, the strongest associations with a larger authorization dosage (4-10 grams vs. 1-3 grams) were observed for Veterans receiving benefits for mental health conditions in combination with other health conditions (OR = 3.47 compared with those with no mental health conditions). A larger authorization dosage was associated with province of residence (OR = 3.36 for New Brunswick compared with Ontario), earlier year of authorization (OR = 2.19 for 2014) compared with 2016, being male (OR = 1.68), active participation in a rehabilitation program (OR = 1.45), land environment at the time of release from military service (OR = 1.24) compared with air environments, and involuntary release from service (OR = 1.65) and medical release (OR = 1.11) compared with voluntary released. Discussion: Factors associated with larger CMP authorization dosage among military Veterans in Canada appeared multifactorial, spanning socio-demographic, health, and military characteristics. This complexity should be considered by treatment providers and clinicians working with military Veterans. LAY SUMMARYThis work investigated factors associated with medicinal cannabis authorization dosage among 9,104 Canadian Armed Forces Regular Force Veterans in Canada with a valid Cannabis for Medicinal Purposes (CMP) reimbursement on Dec. 31, 2020, and identified various socio-demographic, Veterans Affairs Canada (VAC) pensionable conditions, and military service characteristics associated with higher-dose medicinal cannabis authorizations. Among those with higher dose reimbursements were Veterans under the age of 30 years, males, those receiving benefits for health conditions (e.g., hearing loss, musculoskeletal, or mental health conditions), those participating in VAC rehabilitation services, those with an earlier year of reimbursement, those who were released involuntarily from service, and those indicating land military environment service at date of release. In statistical models investigating the impact of multiple factors, some of the strongest associations with higher dosages were observed for Veterans with mental health conditions, those with earlier reimbursements, and province of residence.
引用
收藏
页码:56 / 70
页数:15
相关论文
共 43 条
[21]   Medicinal versus recreational cannabis use: Patterns of cannabis use, alcohol use, and cued-arousal among veterans who screen positive for PTSD [J].
Loflin, Mallory ;
Earleywine, Mitch ;
Bonn-Miller, Marcel .
ADDICTIVE BEHAVIORS, 2017, 68 :18-23
[22]   The effect of military deployment on mental health [J].
Lyk-Jensen, Stephanie Vincent ;
Weatherall, Cecilie Dohlmann ;
Jepsen, Peter Winning .
ECONOMICS & HUMAN BIOLOGY, 2016, 23 :193-208
[23]  
Metrik Jane, 2018, Transl Issues Psychol Sci, V4, P6, DOI 10.1037/tps0000133
[24]   Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study [J].
Neumeister, A. ;
Normandin, M. D. ;
Pietrzak, R. H. ;
Piomelli, D. ;
Zheng, M. Q. ;
Gujarro-Anton, A. ;
Potenza, M. N. ;
Bailey, C. R. ;
Lin, S. F. ;
Najafzadeh, S. ;
Ropchan, J. ;
Henry, S. ;
Corsi-Travali, S. ;
Carson, R. E. ;
Huang, Y. .
MOLECULAR PSYCHIATRY, 2013, 18 (09) :1034-1040
[25]   Cannabinoid interventions for PTSD: Where to next? [J].
Ney, Luke J. ;
Matthews, Allison ;
Bruno, Raimondo ;
Felmingham, Kim L. .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2019, 93 :124-140
[26]  
Ng Jeremy Y, 2021, CMAJ Open, V9, pE342, DOI 10.9778/cmajo.20200187
[27]   Treating Chronic Pain with SSRIs: What Do We Know? [J].
Patetsos, Elias ;
Horjales-Araujo, Emilia .
PAIN RESEARCH & MANAGEMENT, 2016, 2016
[28]  
Public Health, MIL EXP INT
[29]   Cannabis use among Canadian Armed Forces members and Veterans: discussion from a 2017 CIMVHR Forum working group [J].
Richardson, J. Don ;
St Cyr, Kate ;
Jetly, Rakesh ;
Heber, Alexandra ;
Busse, Jason W. ;
Balodis, Iris ;
MacKillop, James ;
Meakin, Carmen ;
Marlborough, Michelle .
JOURNAL OF MILITARY VETERAN AND FAMILY HEALTH, 2019, 5 (02) :209-213
[30]  
Rotermann M, 2018, HEALTH REP, V29, P10